Master's degree in law from Heilongjiang University.

He was the project manager of Guotai Securities, the general manager of the Northeast Division of Cheung Kong Securities Investment Banking, and the deputy general manager of the Corporate Finance Department of Yangtze River Paris Paragon Securities. He joined CASI in 2006 and is now the MD and a member of Intelligent medical group. 

Xu Tiejun has presided over investments in high quality projects such as Siasun (300024), Xinguang Optic-oelectronics (688011) and Baiao Biotechnology. He focuses on investments in medical fields such as CDMO, vaccines, and innovative drugs.